A novel ␤-lactamase gene, bla OXA-61 , from Campylobacter jejuni GC015 was cloned and its nucleotide sequence determined. bla OXA-61 encodes a protein of 257 amino acids in which the active-site STFK tetrad and conserved class D ␤-lactamase motifs YGN and KTG were identified. A conserved sequence upstream of bla OXA-61 is required for expression in Campylobacter.
The majority of thermotolerant Campylobacter species, including Campylobacter jejuni, the leading cause of bacterial food-borne diarrheal disease throughout the world (6) , show various levels of resistance to the antimicrobial agents penicillin G, ampicillin, amoxicillin, ticarcillin, and piperacillin (9) . Although ampicillin is not considered useful for the treatment of Campylobacter infections (5) , 83 to 92% of strains of C. jejuni produce ␤-lactamase (9, 16) and ␤-lactamase-positive strains have been reported to be significantly more resistant to amoxicillin, ampicillin, and ticarcillin than ␤-lactamase-negative strains (9) .
Ambler molecular class D enzymes (oxacillinases) are active-site serine ␤-lactamases (11) , are poorly inhibited by clavulanic acid (7) , and generally have a preference for penam substrates including oxacillin (10) . Oxacillinases may be chromosomally encoded (4); however, most oxacillinase genes form part of gene cassettes in class 1 integrons (14) and the frequent location of OXA genes on mobile genetic elements (plasmids or integrons) facilitates their spread (8) . In Campylobacter, ampicillin resistance and the associated ␤-lactamase production are chromosomally encoded (17) . This study describes the cloning and expression of a novel molecular class D ␤-lactamase structural gene, bla OXA-61 , from a human clinical strain of C. jejuni, GC015, isolated in 2001.
Bacterial strains and plasmids used in this study are listed in Table 1 . Plasmids from both Escherichia coli and C. jejuni were prepared using the Nucleospin Plasmid kit (Macherey-Nagel, Duren, Germany) according to the manufacturer's instructions. ␤-Lactam antibiotics used in this study were ampicillin, piperacillin, carbenicillin, potassium clavulanate, cephalothin, cefotaxime, meropenem, and imipenem. MICs of ␤-lactam antibiotics, with the exception of imipenem, were determined by agar dilution according to the National Committee for Clinical Laboratory Standards method (12) . Imipenem MIC testing was performed using Etest strips. For C. jejuni, MIC testing was performed as previously described (1) . Potassium clavulanate was used at a concentration of 2 g/ml.
To amplify the putative C. jejuni ␤-lactamase gene, primers DBla-F and DBla-R ( Table 2) were designed utilizing the sequence of the putative periplasmic class D ␤-lactamase gene reported in the C. jejuni ATCC 11168 genome sequence (Gen-Bank accession no. NC_002163) and targeted the nucleotide sequences of the serine ␤-lactamase STFK (serine-X-X-lysine) active-site tetrad and the class D ␤-lactamase domain LKIS-X-X-EQ, respectively. A 310-bp PCR product, amplified from a crude lysate prepared from C. jejuni strain GC015, was ligated into pGU0202 (2), followed by CaCl 2 -mediated transformation into E. coli HB101 and sequencing using primers pDA2-F and pDA2-R ( Table 2 ). Sequencing of products was performed using the ABI 377 sequencer (Applied Biosystems, Foster City, CA) after dye terminator cycle sequencing (ABI Prism BigDye terminator sequencing kit; Applied Biosystems).
To determine the precise sequence of the putative ␤-lactamase gene, including its promoter region, inverse PCR was performed using ClaI-digested, self-ligated C. jejuni GC015 genomic DNA as a template. Pfu turbo proofreading DNA polymerase (Stratagene, La Jolla, CA) and inverse PCR primers Inv.D-F and Inv.D-R (Table 2) , designed from the known sequence of the amplified segment of DNA, were used to amplify a 2.2-kb PCR product. Sequences were analyzed in silico to construct the entire GC015 putative ␤-lactamase DNA
sequence. An open reading frame of 774 bp was identified which encoded a putative 257-amino-acid protein, designated OXA-61. The serine ␤-lactamase active-site STFK tetrad (positions 58 to 61) and conserved motifs characteristic of molecular class D ␤-lactamase structural elements, YGN (positions 133 to 135) and KTG (positions 196 to 198), were identified (Fig. 1 ). The overall GC content of bla oxa-61 is 27.4%, which is similar to the overall GC content (30.6%) of the C. jejuni ATCC 11168 chromosome (15) . Database searches carried out through the National Center for Biotechnology Information using the BLAST program (3) showed that the putative product of bla OXA-61 had only one amino acid substitution, Glu 3 Gly (position 202), compared to a putative class D ␤-lactamase from C. jejuni ATCC 11168 (GenBank accession no. NC_002163). A 122-bp region identified directly upstream of bla OXA-61 showed 99% identity with a region directly upstream of the C. jejuni ATCC 11168 putative class D ␤-lactamase gene. OXA-61 showed the highest identity to the oxacillinase FUS-1 (45%) from Fusobacterium nucleatum (GenBank acces-sion no. AAP69916) and also shares identity with OXA-10 (37%), OXA-23 (35%), and OXA-27 (34%) (GenBank accession no. AAB60534, AAS59523, and AAG35609, respectively).
Three plasmid constructs were generated utilizing the previously described shuttle vector pGU0202 (2) ( Table 1) to determine whether bla OXA-61 was expressed using its own promoter sequences and whether the entire 122-bp sequence upstream of the ␤-lactamase gene was required for expression. Thus generated recombinant plasmids pGU0401, pGU0402, and pGU0403 were used to transform ␤-lactamase-negative C. jejuni strain 428, which does not harbor a homologue of bla OXA-61 (data not shown), and E. coli HB101. ␤-Lactam MICs for E. coli HB101 and C. jejuni 428 were then compared to those for E. coli and C. jejuni 428 carrying bla OXA-61 (Table  3) .
Recombinant plasmids pGU0401 and pGU0402 conferred a Ն32-fold rise in the MICs of ampicillin, piperacillin, and carbenicillin in C. jejuni 428 cells, indicating a functional ␤-lactamase being expressed from its own promoter regions; resistance to cefotaxime and imipenem was not conferred. Consistent with the class D ␤-lactamases, clavulanic acid, at a concentration of 2 g/ml, did not significantly inhibit hydrolysis of the penicillins by bla OXA-61 . The meropenem MIC increased fivefold; however, pGU0202 is a multicopy plasmid (Ͼ50 copies/cell) and weak carbapenemase activity has been reported previously from recombinant strains expressing cloned oxacillinase genes (14) . Truncation of the sequence upstream of the bla OXA-61 putative Ϫ35 promoter region in recombinant plasmid pGU0403 resulted in reduction of ␤-lactam MICs to the same level as the ␤-lactam-susceptible, wild-type C. jejuni strain 428. RNA primer extension analysis is required to determine the transcription start point for bla OXA-61 in C. jejuni; the exact function of the 122-bp sequence upstream of bla OXA-61 remains to be determined.
In E. coli, the bla OXA-61 promoter region is only poorly recognized, resulting in weak transcription of the ␤-lactamase gene. A four-to eightfold rise in the carbenicillin MIC and a two-to fourfold rise in the ampicillin MIC were still conferred by bla OXA-61 , indicating a low level of transcription of bla OXA-61 from its promoter region in E. coli.
This study indicates that OXA-61 may contribute to resis- DBla-F  PCR  5Ј-TTT GGA TCC CGC CAC TT-3Ј  DBla-R  PCR  5Ј-TTC GGA TCC GCT TAT TTT  TAG T-3Ј  pDA2-F  Sequencing  5Ј-GAA GAA CAG TAT GTC GAG  CTA-3Ј  pDA2-R  Sequencing  5Ј-TGT TGT GTG GAA TTG TGA  GC- on October 14, 2017 by guest http://aac.asm.org/ tance to ␤-lactams in C. jejuni. Future biochemical analyses will determine its functional classification according to the scheme of Bush et al. (7) . Nucleotide sequence accession number. The nucleotide sequence of bla OXA-61 has been deposited in GenBank under accession number AY587956.
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